144 related articles for article (PubMed ID: 37539493)
21. INPP4B-mediated tumor resistance is associated with modulation of glucose metabolism via hexokinase 2 regulation in laryngeal cancer cells.
Min JW; Kim KI; Kim HA; Kim EK; Noh WC; Jeon HB; Cho DH; Oh JS; Park IC; Hwang SG; Kim JS
Biochem Biophys Res Commun; 2013 Oct; 440(1):137-42. PubMed ID: 24051093
[TBL] [Abstract][Full Text] [Related]
22. lncRNA RNCR2 facilitates cell proliferation and epithelial-mesenchymal transition in melanoma through HK2-mediated Warburg effect via targeting miR-495-3p.
Duan BX; Geng XR; Wu YQ
Neoplasma; 2021 Jul; 68(4):692-701. PubMed ID: 33724862
[TBL] [Abstract][Full Text] [Related]
23. Hexokinase 2 promoted cell motility and proliferation by activating Akt1/p-Akt1 in human ovarian cancer cells.
Tian X; Liu D; Zuo X; Sun X; Wu M; Li X; Teng Y
J Ovarian Res; 2022 Aug; 15(1):92. PubMed ID: 35953860
[TBL] [Abstract][Full Text] [Related]
24. Effects of miR-202-5p silencing PIK3CA gene expression on proliferation, invasion, and epithelial-mesenchymal transition of cervical cancer SiHa cells through inhibiting PI3K/Akt/mTOR signaling pathway activation.
Zheng Y; Xie L; Xu S; Yan W; Zhang H; Meng Y; Liu J; Wei X
Mol Cell Biochem; 2021 Nov; 476(11):4031-4044. PubMed ID: 34244973
[TBL] [Abstract][Full Text] [Related]
25. Circ-PRMT5 enhances the proliferation, migration and glycolysis of hepatoma cells by targeting miR-188-5p/HK2 axis.
Ding Z; Guo L; Deng Z; Li P
Ann Hepatol; 2020; 19(3):269-279. PubMed ID: 32089501
[TBL] [Abstract][Full Text] [Related]
26. Knockdown of LncRNA-UCA1 suppresses chemoresistance of pediatric AML by inhibiting glycolysis through the microRNA-125a/hexokinase 2 pathway.
Zhang Y; Liu Y; Xu X
J Cell Biochem; 2018 Jul; 119(7):6296-6308. PubMed ID: 29663500
[TBL] [Abstract][Full Text] [Related]
27. Comprehensive analysis of microRNA-regulated protein interaction network reveals the tumor suppressive role of microRNA-149 in human hepatocellular carcinoma via targeting AKT-mTOR pathway.
Zhang Y; Guo X; Xiong L; Yu L; Li Z; Guo Q; Li Z; Li B; Lin N
Mol Cancer; 2014 Nov; 13():253. PubMed ID: 25424347
[TBL] [Abstract][Full Text] [Related]
28. MicroRNA-429 inhibits cancer cell proliferation and migration by targeting the AKT1 in melanoma.
Huang D; Wang F; Wu W; Lian C; Liu E
Cancer Biomark; 2019; 26(1):63-68. PubMed ID: 31322550
[TBL] [Abstract][Full Text] [Related]
29. Resibufogenin suppresses tumor growth and Warburg effect through regulating miR-143-3p/HK2 axis in breast cancer.
Guo Y; Liang F; Zhao F; Zhao J
Mol Cell Biochem; 2020 Mar; 466(1-2):103-115. PubMed ID: 32006291
[TBL] [Abstract][Full Text] [Related]
30. PLOD1 promotes cell growth and aerobic glycolysis by regulating the SOX9/PI3K/Akt/mTOR signaling pathway in gastric cancer.
Zhang Y; Wu Y; Su X
Front Biosci (Landmark Ed); 2021 Aug; 26(8):322-334. PubMed ID: 34455762
[No Abstract] [Full Text] [Related]
31. miR-34a and miR-125a-5p inhibit proliferation and metastasis but induce apoptosis in hepatocellular carcinoma cells via repressing the MACC1-mediated PI3K/AKT/mTOR pathway.
Zhang YM; Wu QM; Chang LY; Liu JC
Neoplasma; 2020 Sep; 67(5):1042-1053. PubMed ID: 32484698
[TBL] [Abstract][Full Text] [Related]
32. MiR-3662 suppresses cell growth, invasion and glucose metabolism by targeting HK2 in hepatocellular carcinoma cells.
Ye J; Xiao X; Han Y; Fan D; Zhu Y; Yang L
Neoplasma; 2020 Jul; 67(4):773-781. PubMed ID: 32726127
[TBL] [Abstract][Full Text] [Related]
33. Long Non-coding RNA LOXL1-AS1 Facilitates Colorectal Cancer Progression via Regulating miR-1224-5p/miR-761/HK2 Axis.
Guo T; Peng S; Liu D; Li Y
Biochem Genet; 2022 Dec; 60(6):2416-2433. PubMed ID: 35441953
[TBL] [Abstract][Full Text] [Related]
34. Kaempferol impairs aerobic glycolysis against melanoma metastasis via inhibiting the mitochondrial binding of HK2 and VDAC1.
Zheng X; Pan Y; Yang G; Liu Y; Zou J; Zhao H; Yin G; Wu Y; Li X; Wei Z; Yu S; Zhao Y; Wang A; Chen W; Lu Y
Eur J Pharmacol; 2022 Sep; 931():175226. PubMed ID: 36007607
[TBL] [Abstract][Full Text] [Related]
35. HBXIP accelerates glycolysis and promotes cancer angiogenesis via AKT/mTOR pathway in bladder cancer.
Liu X; Li H; Che N; Zheng Y; Fan W; Li M; Li X; Xuan Y
Exp Mol Pathol; 2021 Aug; 121():104665. PubMed ID: 34216584
[TBL] [Abstract][Full Text] [Related]
36. MiR-129 inhibits cell proliferation and metastasis by targeting ETS1 via PI3K/AKT/mTOR pathway in prostate cancer.
Xu S; Ge J; Zhang Z; Zhou W
Biomed Pharmacother; 2017 Dec; 96():634-641. PubMed ID: 29035829
[TBL] [Abstract][Full Text] [Related]
37. Licochalcone A suppresses hexokinase 2-mediated tumor glycolysis in gastric cancer via downregulation of the Akt signaling pathway.
Wu J; Zhang X; Wang Y; Sun Q; Chen M; Liu S; Zou X
Oncol Rep; 2018 Mar; 39(3):1181-1190. PubMed ID: 29286170
[TBL] [Abstract][Full Text] [Related]
38. Hexokinase 2 (HK2), the tumor promoter in glioma, is downregulated by miR-218/Bmi1 pathway.
Liu H; Liu N; Cheng Y; Jin W; Zhang P; Wang X; Yang H; Xu X; Wang Z; Tu Y
PLoS One; 2017; 12(12):e0189353. PubMed ID: 29220380
[TBL] [Abstract][Full Text] [Related]
39. Circ-FOXM1 contributes to cell proliferation, invasion, and glycolysis and represses apoptosis in melanoma by regulating miR-143-3p/FLOT2 axis.
Tian S; Han G; Lu L; Meng X
World J Surg Oncol; 2020 Mar; 18(1):56. PubMed ID: 32183822
[TBL] [Abstract][Full Text] [Related]
40. Quercetin suppresses the mobility of breast cancer by suppressing glycolysis through Akt-mTOR pathway mediated autophagy induction.
Jia L; Huang S; Yin X; Zan Y; Guo Y; Han L
Life Sci; 2018 Sep; 208():123-130. PubMed ID: 30025823
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
